Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Triple Negative Breast Neoplasms × Bevacizumab × Clear all

Phase

Phase 2 18 Phase 1 4 Phase 1/2 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 85 Ovarian Neoplasms 31 Breast Neoplasms 29 Carcinoma, Non-Small-Cell Lung 28 Colonic Neoplasms 23 Rectal Neoplasms 20 Fallopian Tube Neoplasms 17 Neoplasms 16 Neoplasm Metastasis 13 Carcinoma, Hepatocellular 13 Glioblastoma 11 Lung Neoplasms 10 Brain Neoplasms 8 Carcinoma, Renal Cell 7 Uterine Cervical Neoplasms 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Intestinal Neoplasms 5 Gastrointestinal Neoplasms 5 Digestive System Neoplasms 5 Brenner Tumor 5 Recurrence 4 Peritoneal Neoplasms 4 Glioma 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma of Lung 4 Rectal Diseases 3 Non-Squamous Non-Small Cell Lung Cancer 3 Liver Neoplasms 3 Intestinal Diseases 3 Gastrointestinal Diseases 3

Interventions

Paclitaxel 23 Carboplatin 22 Capecitabine 18 Gemcitabine 16 130-nm albumin-bound paclitaxel 16 pembrolizumab 14 Cyclophosphamide 12 atezolizumab 9 Epirubicin 9 sacituzumab govitecan 8 Albumin-Bound Paclitaxel 8 eribulin 6 Vinorelbine 6 Doxorubicin 6 Drug Therapy 5 camrelizumab 4 Docetaxel 4 Cisplatin 4 Injections 3 pegfilgrastim 2 olaparib 2 famitinib 2 Filgrastim 2 Everolimus 2 veliparib 1 trilaciclib 1 toripalimab 1 taxane 1 niraparib 1 ipatasertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05806060 2026-03-25

BCTOP-T-M01

Fudan University

Phase 3 Recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡